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ABSTRACT 
 
 
Introduction: The late menopausal transition is a time of increased risk of 
depression in the general population.  Nonetheless, mood course during the late 
menopausal transition in women with bipolar disorder in relatively unknown.   
Methods: Mood state data in 519 reproductive age women (5989 clinic visits), 
116 late menopausal transition (perimenopausal) women (2046 visits), and 133 
postmenopausal women (1,437 visits) with bipolar disorder who were receiving 
optimized naturalistic treatment in the multisite STEP-BD study over an average 
of 19.8±15.5 months were analyzed for proportion of clinic visits with syndromal 
depression, mood elevation and euthymia between the three groups.  History of 
postpartum and perimenstrual mood exacerbation as well as hormone therapy 
use were evaluated as potential predictors of mood.   
Results: No significant difference in the proportion of clinic visits with syndromal 
depression was found between reproductive age (18.1%), perimenopausal 
(18.1%) and postmenopausal (19.3%) women.  Reproductive age women had 
significantly greater proportion of visits with syndromal mood elevation (5.3%) 
compared to perimenopausal (4.1%, Z=2.1, p<0.05) and postmenopausal (3.0%, 
Z=4.1, p<0.001) women. Reproductive age women also had significantly greater 
proportion of clinic visits in a euthymic state (29.2%) compared to 
postmenopausal (26.0%, Z=2.7,p<0.01) and non-signifcantly greater than 
perimenopausal (28.0%). Thirteen women who transitioned from perimenopause 
vi 
 
 
 
to postmenopause during the study had significantly greater proportion of visits 
with syndromal depression (24.4%) χ2 (3, N = 9960) = 19.8, p <.0002 (but not 
visits with mood elevation (3.2%) nor euthymia (29%)) than reproductive age 
women, perimenopausal women and postmenopausal women. A history of 
perimenstrual and or postpartum mood exacerbation did not significantly alter 
mood course for perimenopausal women.  Hormone therapy use in 
perimenopausal and postmenopausal women was not associated with visits in a 
depressed state. Women who were excluded, most often due to lack of 
menstrual cycle data, had more visits depressed, compared to included subjects.   
Conclusions: While proportion of clinic visits with syndromal depression did not 
differ among the three reproductive groups, thirteen women who had recorded 
transition from perimenopause to postmenopause showed significantly greater 
depression than reproductive age, perimenopausal or postmenopausal women.  
Proportion of visits with euthymia or with syndromal mood elevation decreased 
from reproductive age to perimenopausal to postmenopausal women.  Reported 
history of mood exacerbation during times of hormonal fluctuation, or current use 
of hormone therapy, was not significantly associated with depression during the 
perimenopause. Limitations include women excluded due to absence of 
menstrual data. Future studies should include hormonal assessments. 
vii 
 
 
 
 
TABLE of CONTENTS 
 
ABSTRACT ...................................................................................................iv 
CHAPTER I ...................................................................................................................11 
1 INTRODUCTION ......................................................................................... 11 
1.1 Bipolar Disorder: Diagnosis, Prevalence and Dysfunction ................... 11 
1.2 Bipolar Depression and Women ........................................................... 12 
1.3 Mood and Menopause .......................................................................... 13 
1.4 Depression and Menopause ................................................................ 13 
1.5 Menopausal Endocrinology and Mood ................................................. 14 
1.6 Hormone Therapy and Mood ............................................................... 15 
1.7 Bipolar Disorder and Menopause ......................................................... 16 
1.8 Perimenstrual Mood Symptoms and Postpartum Mood Episodes ....... 18 
1.9 Objectives (Overview) .......................................................................... 18 
CHAPTER II ..................................................................................................................20 
2 RELATED WORK ........................................................................................ 20 
2.1 Bipolar Disorder ................................................................................... 20 
2.2 Reproductive Events ............................................................................ 20 
2.3 Bipolar Disorder and Perimenopause................................................... 21 
CHAPTER III .................................................................................................................22 
3 DETAILS OF RESEARCH ....................................................................... 22 
3.1 Subjects ............................................................................................... 22 
3.1.1 Subject Selection and Mood Evaluation ........................................... 22 
3.1.2 Subject Cohort Classification ............................................................ 23 
3.2 Procedure ............................................................................................. 24 
3.3 Statistical Analysis................................................................................ 25 
3.3.1 Bipolar Depression ........................................................................... 26 
3.3.2 Mood Elevation and Euthymia .......................................................... 26 
3.3.3 Perimenstrual and Postpartum Mood Exacerbation ......................... 26 
3.3.4 Hormone Therapy ............................................................................. 27 
3.3.5 Transitioning Peri to Postmenopause ............................................... 27 
3.3.6 Covariates, Age and Missing Data.................................................... 27 
CHAPTER IV .................................................................................................................29 
4 RESULTS ................................................................................................ 29 
4.1 Study Sample ....................................................................................... 29 
4.1.1 Reproductive Age Women ................................................................ 29 
4.1.2 Menopausal Transition Women ........................................................ 30 
4.1.3 Postmenopausal Women .................................................................. 30 
4.1.4 Transitioning Peri to Postmenopausal Women ................................. 30 
4.2 Sample Characteristics ........................................................................ 31 
4.3 Overall Mood State Description by Reproductive Group ...................... 32 
viii 
 
 
 
4.4 Primary Hypothesis: Proportion of Visits with Syndromal Depression 
Across Reproductive Stages ........................................................................... 32 
4.5 Secondary Hypotheses ........................................................................ 33 
4.5.1 Proportion of Visits with Syndromal Mood Elevation across 
Reproductive Stages ....................................................................................... 33 
4.5.2 Proportion of Visits in Euthymic Mood across Reproductive Stages 34 
4.5.3 History of Perimenstrual and or Postpartum Mood Exacerbation ..... 34 
4.5.4 Hormone Therapy Use ..................................................................... 35 
4.5.5 Women Transitioning from Perimenopause to Postmenopause ....... 36 
4.5.6 Mood state of included compared to excluded subjects ................... 37 
4.5.7 Mood State by Age ........................................................................... 37 
CHAPTER V ..................................................................................................................38 
5 CONCLUSIONS ...................................................................................... 38 
5.1.1 Syndromal Bipolar Depression ......................................................... 38 
5.1.2 Syndromal Mood Elevation ............................................................... 38 
5.1.3 Euthymic Mood ................................................................................. 39 
5.1.4 History of Mood Disruption Associated with Reproductive Events .... 39 
5.1.5 Hormone Therapy ............................................................................. 39 
5.1.6 Women Transitioning from Peri to Post Menopause ......................... 39 
5.1.7 Mood State in Included compared to Excluded Women ................... 40 
5.2 Discussion and Comparison to Published Data ................................... 40 
5.2.1 Bipolar Depression in Menopausal Transition .................................. 40 
5.2.2 Mood Elevation in Menopausal Transition ........................................ 41 
5.2.3 Euthymia and Menopausal Transition ............................................... 41 
5.2.4 Potential Confounders ...................................................................... 42 
5.2.5 History of Mood Exacerbation with Reproductive Events ................. 43 
5.2.6 Bipolar Mood Episodes and Hormone Therapy ................................ 44 
5.3 Strengths and Limitations ..................................................................... 44 
5.3.1 Strengths .......................................................................................... 44 
5.3.2 Limitations ........................................................................................ 45 
5.4 Future Work ......................................................................................... 47 
TABLES and FIGURES……………………………………………………………….48 
REFERENCES ..............................................................................................................57 
ix 
 
 
 
List of Tables & Figures 
 
 
 
Figure 1 Proportion of Clinic Visits in Mood State by Reproductive Cohort of 
Women with Bipolar Disorder, by Visit 
 
Figure 2 Proportion of Clinic Visits in Mood State by Reproductive Cohort of 
Women with Bipolar Disorder, by Woman 
 
Figure 3 Proportion of Visits in Mood State by Age in Women with Bipolar 
Disorder 
 
Table 1 Subject Characteristics 
 
Table 2  Reproductive History of Subjects 
 
Table 3  Pair-wise Comparisons of Proportion of Clinic Visits in Depression,  
Mood Elevation or Euthymia by Reproductive Cohort 
 
Table 4  Proportion of Visits in a Depression or Mood Elevation by 
Reproductive Group Reporting a Positive or Negative History of 
Perimenstrual and or Postpartum  Mood Exacerbation. 
 
Table 5 Proportion of Visits in a Depression or Mood Elevation by 
Exogenous Hormone Use 
 
Table 6   Proportion of Visits in Mood State by Reproductive Age Group: I 
  Included vs Excluded Women 
 
 
  
 
 
 
 
x 
 
 
 
List of Abbreviations 
 
 
 
ADE  Affective Disorder Evaluation 
APA  American Psychiatric Association 
BD  Bipolar Disorder 
CES-D Center for Epidemiologic Studies Depression Scale  
CMF  Clinical Monitoring Form 
DSM-IV Diagnostic and Statistical Manual, IV edition 
FMP   Final Menstrual Period 
FSH   Follicular Stimulating Hormone 
HT  Hormone Therapy 
MADRS Montgomery Aspberg Depression Scale 
MINI  Mini International Neuropsychiatric Interview 
NOS  Not Otherwise Specified 
OCP  Oral Contraceptive Pill 
SCID  Structured Clinical Interview for DSM IV 
SD  Standard Deviation 
SSRI  Selective Serotonin Reuptake Inhibitor 
STEP-BD Systematic Treatment Enhancement Protocol – Bipolar Disorder 
STRAW Stages of Reproductive Aging Workshop  
SWAN Study of Women Across the Nation 
YMRS  Young Mania Rating Scale  
Yr   Year
11 
 
 
 
CHAPTER I 
1 INTRODUCTION 
1.1 Bipolar Disorder: Diagnosis, Prevalence and Dysfunction 
 
Bipolar disorder is a common, chronic, serious psychiatric illness characterized 
by major depressive episodes during which an individual experiences at least two 
weeks of depressed mood or loss of pleasure or interest, and by mood elevation 
episodes (mania or hypomania) where one experiences a persistently elevated, 
expansive or irritable mood for at least four days.  Persons with bipolar disorder 
can experience depression and mania simultaneously (mixed episodes) and can 
have psychotic symptoms (delusions, hallucinations, disorganized behavior or 
speech) during episodes of either polarity.   
The bipolar disorders include a spectrum of diagnoses. Bipolar I may be 
considered the most severe, as it requires at least one mood elevation (manic or 
mixed) episode that is serious in the sense of entailing psychotic symptoms, 
hospitalization, or severe impairment of interpersonal or occupational function, 
commonly yielding serious adverse life events such as incarceration, bankruptcy, 
divorce, or employment termination.  Bipolar II is characterized by hypomanias 
where the mood elevation is not as severe as bipolar I, but also entails 
depression that can be more chronic and severe than those seen in bipolar I 
disorder. Bipolar Disorder Not Otherwise Specified (NOS) represents a residual 
class of disorder that include bipolar features that do not meet criteria for bipolar I 
or II  (APA 2000). 
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Bipolar disorder is a common affliction. Bipolar disorder I occurs in a 
proximately 1-2% of the population (Regier, Myers et al. 1984; Kessler, Berglund 
et al. 2005), bipolar II another 1% and bipolar NOS 2%, with a  total of 3.9 to 
5.5% of U.S. population affected (Angst 1998; Kessler, Berglund et al. 2005; 
Merikangas, Akiskal et al. 2007).  
Bipolar disorder causes marked dysfunction. Bipolar disorder has been 
reported to have a greater prevalence of severe impairment (70%) across life 
domains (work, home, social) than any other psychiatric disorder as well as any 
chronic medical disorder (Druss, Hwang et al. 2009). 
1.2 Bipolar Depression and Women 
While bipolar disorder is equally diagnosed among men and women, women 
more frequently experience depressive episodes (Angst 1978; Altshuler, Kupka 
et al. 2010), rapid cycling of mood episodes (more than four mood episodes per 
year) (Dunner, Patrick et al. 1977; Altshuler, Kupka et al. 2010), and mixed 
mania which requires not only syndromal mania, but also concurrent syndromal 
depression (McElroy, Keck et al. 1992; Arnold, McElroy et al. 2000). Women are 
at particular risk of depression during times of physiological hormonal fluctuations 
like the postpartum (Kendell, Chalmers et al. 1987).  Yet little is known about the 
mood episode course in bipolar disorder during the menopausal transition, 
another time of reproductive hormonal fluctuation. 
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1.3 Mood and Menopause 
 
During the menopausal transition, the most frequent psychological symptoms for 
women in the general population are irritability, tearfulness, anxiety, depression, 
emotional lability, low energy, low motivation, poor concentration and interrupted 
sleep (Greene 1976; Hunter 1990; Avis, Brambilla et al. 1994). These symptoms 
may overlap or potentially contribute to a diagnosis of either depression or mood 
elevation.  
1.4 Depression and Menopause 
While most women do not experience a depressive episode during the 
perimenopausal transition, an expanding literature is replicating, both cross-
sectionally and longitudinally, an increased risk of major (and minor) depression 
in women with a history of depression as well as those with no history of a mood 
disorder (Freeman, Sammel et al. 2004; Schmidt, Haq et al. 2004; Bromberger 
2006; Cohen, Soares et al. 2006).  
Most recently, Bromberg et al (Bromberger, Schott et al. 2010) reported from 
the Study of Women Across the Nation (SWAN) on a longitudinal multisite 
community based sample of 3302 multiethnic women 42-52 years old not using 
exogenous hormones. Within these women, being peri or postmenopausal 
compared with being premenopausal was significantly associated with increased 
depression with Center for Epidemiologic Studies Depression Scale (CES-D) 
score of 16 or higher.  
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Freeman et al summarized the literature noting that recent longitudinal cohort 
studies indicated the likelihood of depressed mood in the menopausal transition 
was approximately 30% to 300% greater compared with that during 
premenopause.  Women with a history of depression were nearly five times more 
likely to have a diagnosis of major depression in the menopausal transition, 
whereas women with no history of depression were two to four times more likely 
to report depressed mood compared with premenopausal women.  She also 
reviewed literature finding the early postmenopause was also associated with 
increased depression (Freeman 2010).  
1.5 Menopausal Endocrinology and Mood 
Neurobiological changes during the menopausal transition indicate the 
importance of evaluating the relationship between reproductive hormonal 
fluctuation and mood during this time period. Sex steroid receptors are found in 
the cognitive and mood processing regions of the brain, including the amygdala, 
hippocampus, cingulate cortex, locus ceruleus, midbrain raphe, and central grey 
matter (McEwen, Alves et al. 1997).  Estradiol stimulates synaptogenesis, and 
leads to a significant increase in serotonin 5HT2a binding sights, increase in 
serotonin synthesis, decrease in monoamine oxidase concentrations, and thus in 
sum, to a plausible antidepressant-like effect (Kendall, Stancel et al. 1982).  
Gonadal steroids such as estrogen and progesterone fluctuate greatly during 
the menopausal transition, especially in the early transition when menstrual 
15 
 
 
 
cycles start to become irregular (change by at least seven days from regular 
cycle frequency).  It is during the late menopausal transition (greater than 60 
days between menstruations) that these sex steroids have their greatest decline. 
After 365 days of not menstruating a woman is considered postmenopausal and 
estrogen and progesterone levels are low. 
Higher testosterone levels may contribute to higher depressive symptoms 
during the menopausal transition. This association is independent of menopausal 
status, which remains an independent predictor of higher depressive symptoms 
(Bromberger, Schott et al. 2010). 
1.6 Hormone Therapy and Mood 
While no abnormality of ovarian hormones has been identified that distinguishes 
women with depression from those who remain asymptomatic during the 
menopausal transition, several findings suggest a role of ovarian hormones, 
particularly studies using hormonal therapy, in the onset of these depressions.  
Short term (3-6 week) double-blind, placebo-controlled trials, which used similar 
methodologies found that the same 17 beta estradiol preparation significantly 
decreased depression rating scale scores compared to placebo in 
perimenopausal related major depression or shortened duration until 
improvement of mood (Schmidt, Nieman et al. 2000; Soares, Almeida et al. 2001; 
Rasgon, Altshuler et al. 2002).  Findings also suggest independent effects of 
estrogen on mood and vasomotor symptoms. Specifically, a sustained 
16 
 
 
 
antidepressant effect was observed after discontinuation of estradiol treatment 
despite recrudescence of somatic symptoms. Seven of 10 patients who remained 
well (MADRS<10) after estradiol discontinuation reported reemergence of 
moderate-to-severe hot flushes. (Schmidt, Nieman et al. 2000; Soares, Almeida 
et al. 2001).  
    In fact, when estrogen replacement treatment is combined with selective 
serotonin reuptake inhibitor antidepressants (SSRIs), antidepressant therapeutic 
effects have been found to be improved in postmenopausal women (Zanardi, 
Rossini et al. 2007).  Estradiol depletion has also been associated with increased 
risk of depression (Schmidt 2005).  
     When considering bipolar disorder, in one report of 22 postmenopausal 
women with bipolar disorder, those not taking hormone replacement therapy 
were more likely to report worsening of mood (Freeman, Smith et al. 2002) 
during perimenopause.  While depression may be influenced by estrogen, no 
studies were found regarding the effect estrogen or other reproductive hormones 
during the menopausal transition on mania.  
1.7 Bipolar Disorder and Menopause 
To date, prior studies of women with bipolar disorder in the menopausal 
transition have been small (Kukopulos, Reginaldi et al. 1980; Marsh, Templeton 
et al. 2005; Marsh, Ketter et al. 2009) or retrospective, that is, dependent on 
subject recall (Blehar, DePaulo et al. 1998; Freeman, Sammel et al. 2004). Most 
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involved cross-sectional or retrospective assessment of mood (Kukopulos, 
Reginaldi et al. 1980; Blehar, DePaulo et al. 1998; Freeman, Smith et al. 2002).  
None compared mood episodes in menopausal transition women with those in 
women of reproductive age and postmenopausal women with bipolar disorder. 
Nonetheless, the literature in bipolar disorder suggests an increase in mood 
instability during the menopausal transition (Kukopulos, Reginaldi et al. 1980; 
Blehar, DePaulo et al. 1998; Freeman, Smith et al. 2002; Marsh, Templeton et al. 
2005), particularly an increase in depression (Freeman, Smith et al. 2002; Marsh, 
Templeton et al. 2005) or high rate of depression (Marsh, Ketter et al. 2009).   
One retrospective report (Blehar, DePaulo et al. 1998) found that 
approximately 20% (11/ 56) of postmenopausal women with bipolar I reported 
severe emotional disturbances during the menopausal transition, wth the majority 
of those having depression (13%), and the others experiencing mania (4%), and 
anxiety/agitation (4%).  In another study, 55% (12/22) of postmenopausal women 
with bipolar disorder had perimenopausal worsening of mood episodes, and all 
55% with such worsening experienced increased depressive symptoms while 
over a third (36%, 8/22) also experienced worsening of mood elevations 
(Freeman, Smith et al. 2002).   Kukopulos et al (1980) found 32% of 77 women 
with ‘continuous cycling’ and 25% of 60 women who developed rapid cycling 
bipolar disorder did so during the menopausal transition (20).   
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1.8 Perimenstrual Mood Symptoms and Postpartum Mood Episodes 
Perimenstrual symptoms and postpartum mood episodes have unclear 
relationships with mood during the perimenopause. For example, 
perimenopausal women who were depressed reported more premenstrual 
symptoms over the course of one menstrual cycle than perimenopausal women 
who were not depressed (Richards, Rubinow et al. 2006). In a population-based 
cohort, reporting symptoms of premenstrual syndrome predicted an increased 
risk of depression during perimenopause (Freeman, Sammel et al. 2004). 
Among women with bipolar disorder, the evidence is mixed as to whether a 
postpartum episode indicates greater risk of a mood episode during natural 
menopause (Payne, Roy et al. 2007; Marsh, Templeton et al. 2008; Robertson 
Blackmore, Craddock et al. 2008).  For example, when looking at women with 
bipolar disorder, a reported history of mood disturbance postpartum or across the 
menstrual cycle did not convey an increased risk of mood dysregulation during 
perimenopause (Marsh, Templeton et al. 2005; Payne, Roy et al. 2007).  
On the other hand, among women with unipolar major depressive disorder, a 
postpartum depression may likely confer a greater risk of depression during the 
natural menopause (Payne, Roy et al. 2007). 
1.9 Objectives (Overview) 
• We used prospectively collected systematic clinical data to test the 
primary hypothesis that among women with bipolar disorder, those in 
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the late menopausal transition (perimenopause) experience a greater 
proportion of clinic visits with a major depressive episode than 
reproductive premenopausal women and postmenopausal women.   
• To place the depression results in the larger context of mood course 
in bipolar disorder across reproductive phases, we examined the 
proportion of visits in an elevated mood between the three cohorts, 
without expectation of a significant difference between them. 
• Likewise, we compared the proportion of visits in a euthymic state 
between the three reproductive groups with the hypothesis that the 
perimenopausal group would have fewer visits in euthymia than the 
pre and postmenopausal women. 
• In examining the reproductive continuum, we assessed whether 
reporting a prior experience of mood exacerbation related to 
reproductive events (postpartum, perimenstrual or both) was 
associated with an increased proportion of clinic visits with syndromal 
depressive or mood elevation episodes during the menopausal 
transition.  
• To look for an association of hormone therapy and mood in women 
with bipolar disorder, we compared the proportion of visits with 
syndromal depressive or mood elevation episodes between 
menopausal transition and postmenopausal women taking hormone 
therapy (HT) to those who were not taking HT. 
• Women transitioning from late perimenopause to postmenopause 
had their mood course compared to that of the reproductive age, 
non-transitioning perimenopasual and postmenopausal women. 
20 
 
 
 
CHAPTER II 
2 RELATED WORK 
2.1 Bipolar Disorder 
Dr. Marsh has focused her research on bipolar disorder and women.  With 
respect to bipolar disorder, she has published not only regarding effective 
medication treatment of mania (Ketter, Wang et al. 2005), but also, more relevant 
to this thesis on women, regarding the clinical effectiveness of medications for 
bipolar depression: lamotrigine (Ketter, Brooks et al. 2008), quetiapine (Ketter, 
Brooks et al. 2010) and antidepressants (Bauer, Rasgon et al. 2006).  She has 
also reported on phenomena such as ‘brief’ mood episodes (those with 
subthreshold duration) (Bauer, Grof et al. 2006; Bauer, Glenn et al. 2007; Bauer, 
Glenn et al. 2009); and symptoms such as sleep (Bauer, Glenn et al. 2008; 
Bauer, Glenn et al. 2009) related to the potential overlap of mood disorders and 
menopausal symptoms. 
2.2 Reproductive Events 
In her work focusing on women with mood disorders she has first-authored a 
review paper on bipolar disorder in women discussing the impact of each 
reproductive phase on mood (Marsh and Vemuri 2006) and presented a case 
study characterized by menstrually entrained mood symptoms in rapid cycling 
bipolar disorder (Becker, Rasgon et al. 2004).  In the context of her thesis, she 
has published articles based on data acquired during the Systematic Treatment 
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Enhancement Program for Bipolar Disorder (STEP-BD) (Ketter, Brooks et al. 
2008; Marsh, Templeton et al. 2008; Marsh, Ketter et al. 2009; Ketter, Brooks et 
al. 2010) and her first authored works are detailed below. 
2.3 Bipolar Disorder and Perimenopause 
In related work, Dr. Marsh found a significant increase in the frequency of 
syndromal depressive episodes in the perimenopause compared to the 
reproductive years in women receiving treatment for bipolar disorder. Specifically 
68% of the 47 perimenopausal age women with bipolar disorder (I,II, or NOS) 
met criteria for experiencing at least one major depressive episode over an 
average of 17 months of prospective monitoring. Depression (but not mood 
elevation) episode frequency significantly increased during the menopausal 
transition compared to reported frequency during patients' reproductive years. 
However, a history of premenstrual and or postpartum mood exacerbations did 
not predict perimenopausal mood episodes. (Marsh, Templeton et al. 2008).  
She found with longitudinal assessment (mean 21 ±18 months) that 78% 
of women age 45- 55 experienced a major depressive episode and that this was 
significantly increased compared to self-report of prior depressive episode 
frequency.  However the mood elevation episode frequency at 32% did not 
significantly increase from subject’s report of prior years (Marsh, Templeton et al. 
2008).   
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CHAPTER III 
3 DETAILS OF RESEARCH 
3.1  Subjects 
3.1.1 Subject Selection and Mood Evaluation  
Prospectively collected systematic clinical data were analyzed for 268 
women with a DSM IV diagnosis of bipolar disorder type I, II, or NOS or 
schizoaffective disorder, bipolar type, who were ages 28 to 38, 42 to 60, and over 
60 at enrollment in STEP-BD (Sachs, Thase et al. 2003).  STEP-BD included 
4108 female and male participants enrolled between September 1998 and 
September 2005 and treated guided by model practice procedures, which 
included published pharmacotherapy guidelines (Sachs, Thase et al. 2003) at 
twelve academic U.S. sites (Baylor College of Medicine, Case Western Reserve 
University, Massachusetts General Hospital, Portland Veteran’s Administration 
Medical Center, Stanford University, University of Colorado, University of 
Massachusetts, University of Oklahoma Health Sciences Center, University of 
Pennsylvania Medical Center, University of Pittsburg, University of Texas Health 
Science Center at San Antonio, and seven community partners). The STEP-BD 
ClinicalTrials.gov identifier is NCT00012558 .  
DSM IV diagnoses were based on assessments using the STEP-BD 
Affective Disorders Evaluation (ADE) (Sachs, Thase et al. 2003), which includes 
the mood disorders module of the Structured Clinical Interview for DSM-IV 
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(SCID) (First, Spitzer et al. 1996) and independently confirmed using the Mini 
International Neuropsychiatric Interview (MINI)  (Sheehan, Lecrubier et al. 1998).  
Longitudinal observation of mood episodes was performed with the STEP-BD 
Clinical Monitoring Form (CMF) (Sachs, Guille et al. 2002) based on DSM IV 
mood episode criteria.  All assessors were psychiatrists trained to use 
standardized criteria for mood and symptom ratings.  Mood at each visit was 
categorized as recovering/recovered (i.e. euthymic), roughening/continued 
symptomatic (i.e. subsyndromal depressive or mood elevation symptoms), 
syndromal depression, or syndromal mood elevation (i.e. syndromal manic, 
hypomanic, or mixed episode) 
3.1.2 Subject Cohort Classification 
Reproductive age, premenopausal, women
 
 were defined as being 28-38 
years old and having menstruation recorded every 60days or fewer.  Self-report 
of regular menstruation was considered evidence of non-pregnancy and intact 
uterus (no hysterectomy). All women meeting the 60days or less menstrual cycle 
frequency criteria were included. 
Menopausal transition, or perimenopausal women, were defined as 
women 42 to 60 years old who had 60 to 365 days between the first days of 
consecutive reported menstruations according to STRAW criteria for the late 
menopausal transition (Soules, Sherman et al. 2001). Using a 60 day compared 
to a 90 day lower limit between menses is more inclusive, and has been found to 
be as accurate in predicting final menstrual period (Harlow, Cain et al. 2006).  
24 
 
 
 
Any woman between the ages of 42 and 60 who at one point during her 
participation in STEP-BD menstruated between 60 and 365days apart was 
considered perimenopausal (even if future cycles were recorded at greater than 
365 days apart).  All of her visits were then included in the perimenopausal 
analysis, based on the assumption that a) there continues to be significant 
hormonal withdrawal within the first months of postmenopause and b) given the 
high degree of missing menstrual cycle data there is a likelihood menstrual 
cycles may have occurred but not have been reported. 
 Postmenopausal women
 
 were defined as over 42years old and having a 
reported menstrual cycle after which 365 days passed without further 
menstruation (i.e. if at any time she had two menstrual cycles less than 365 days 
apart, she was considered perimenopausal). If over 60 years old she was 
considered postmenopausal even if no menstrual cycle data was recorded.   
Transitioning Perimenopausal to postmenopausal women
3.2 Procedure 
 were defined as 
a subgroup of perimenopausal women whose menstrual cycle frequency 
changed from 60 to 365 days to greater than 365 days without menstruation 
during her participation in STEP-BD. This group was used for a separate 
analysis. 
The STEP-BD protocol was approved by the human subjects review panel 
of each site, and subjects provided verbal and written informed consent prior to 
participation. Baseline demographic, diagnostic, illness history, psychiatric 
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comorbidity and reproductive data were obtained from the baseline STEP-BD 
ADE assessments. Longitudinal data regarding mood status as defined by DSM 
IV, treatment received, and menstrual status at each visit were obtained from the 
STEP-BD CMF assessments performed at each clinical visit.  
Specific baseline variables used from the ADE included age, sex, bipolar 
diagnosis, current comorbid psychiatric diagnoses including substance use and 
anxiety disorders, medication at intake (specifically, hormone therapy), age of 
first syndromal mood episode (mood elevation or depression), rapid cycling 
status, history or perimenstrual mood exacerbation, history of postpartum mood 
exacerbation, menstrual and reproductive history including regularity, and parity.  
Variables used from the CMF assessments included current clinical mood status 
(syndromal depression, syndromal mood elevation, or neither syndromal 
depression nor syndromal mood elevation), medications taken (specifically, 
hormone therapy), and self-reported date of first day of most recent menses. 
3.3 Statistical Analysis 
Initial analysis by clinic visit for an overall difference in proportion of clinic 
visits with differing mood states between reproductive age, perimenopausal and 
postmenopausal was performed by Chi square test. The overall analysis was 
also performed by averaging within woman clinic visits by mood state and 
compared across reproductive groups using a generalized linear model. 
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3.3.1 Bipolar Depression 
The primary hypothesis that women with bipolar disorder in the late 
menopausal transition would have a greater proportion of clinic visits in 
syndromal depression than concurrent reproductive age women and 
postmenopausal women was tested by Chi square analyses. Pair-wise 
comparison between any of the two reproductive groups for difference in 
proportion of clinic visits with syndromal depression was performed using a Z test 
of proportions. 
3.3.2 Mood Elevation and Euthymia 
The secondary hypotheses examining the proportion of visits in a) 
syndromal mood elevation and b) euthymic state between the reproductive age, 
perimenopausal and postmenopausal groups, were examined using an 
analogous analysis to that described above for syndromal depression.  
3.3.3 Perimenstrual and Postpartum Mood Exacerbation 
To examine whether the presence compared to the absence of a reported 
history of postpartum and/or perimenstrual mood exacerbation was associated 
with an increased proportion of clinic visits with syndromal depression or 
syndromal mood elevation in the menopausal transition women a within-woman 
analysis using a Z test of proportions, or Z score was used. 
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3.3.4 Hormone Therapy 
The proportions of clinic visits with syndromal depression in women with 
bipolar disorder taking and not taking hormonal therapy (HT) in both the 
perimenopausal and postmenopausal women were compared using a within-
woman Z test of proportions. 
3.3.5 Transitioning Peri to Postmenopause 
Proportion of clinic visits in syndromal depression, elevation and euthymia 
for women transition from late perimenopause to postmenopause was compared 
that of reproductive age, non-transitioning perimenopausal and postmenopausal 
women was compared using a Chi square analysis similar to that described in 
bipolar depression.  A within-woman comparison of mood states in the 
perimenopause compared to postmenopause was performed by t-test. 
3.3.6 Covariates, Age and Missing Data 
Differences between reproductive, menopausal transition and 
postmenopausal women in known covariates of mood severity were examined. 
Possible predictors of recurrence in bipolar disorder were assessed for presence 
of significant differences between reproductive age, perimenopausal and 
postmenopausal women including bipolar diagnostic subtype, rapid cycling 
status, age at onset (Schurhoff, Bellivier et al. 2000), and current comorbid 
anxiety (Simon, Otto et al. 2004) and substance use (Goldstein, Velyvis et al. 
2006) disorders.  
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A statistical description of mood course by 5 year age
An ordinal logistic regression model was used to look at whether 
reproductive stage predicted pervasiveness of mood states.  Euthymia was set 
as the base reference.  
 groupings was also 
performed to screen for an age effect. 
Due to high rate of missing data, a comparison of proportion of visits in each 
mood state (depressed, elevated and euthymic) of included versus excluded 
women was performed by chi square analysis. 
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CHAPTER IV 
4 RESULTS 
4.1 Study Sample 
Of 4,108 participants who enrolled in STEP-BD and had an initial diagnostic 
assessment with the ADE, in the final deliverable 1,740 had complete baseline 
data. Of the original 4,108 enrolled subjects 2,196 were women, 1,548 of whom 
had a recorded age (though not necessarily complete base line data), 488 
women were under the age of 28 and were not included in this analysis.   768 
women met inclusion criteria for one of the three reproductive groups below.  
Total visit count for the three groups was 9960. 
The mean ± SD duration of longitudinal monitoring was 19.8 ± 15.5 months 
overall, with an average of 0.8 ± 0.6 visits a month for the three reproductive 
groups. 
4.1.1 Reproductive Age Women 
There were 640 women (8943 visits) age 28-38 years of whom 533 (6279 visits) 
had information on menses. 107 women (2664 visits) had no information on 
menses.  Of the 533 women with menses information, 519 women (5989 visits) 
met the inclusion criteria of menses within sixty days from consent.  29.7% of 
clinic visits in this age group were missing menstrual cycle data.  
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4.1.2 Menopausal Transition Women 
There were 810 women (with 11803 visits) between 42 and 60 years old.  Of 
these women, 369 had information on menses. From the women with information 
on menses, 116 women (2046 visits) met the criteria to be included in the 
analysis (a record of menses within 60-365days).  43 (488 visits) of the 369 
women with information on menses had a record of menses greater than 365 
days from consent and are considered part of the postmenopausal analysis  
68.8% of clinic visits of women between 42 and 60 years old were missing 
menstrual cycle data. The final perimenopausal women data included 2046 clinic 
visits in 116 women. 
4.1.3 Postmenopausal Women 
Postmenopausal women were between 42 and 83 years old on study entry.    43 
(488 visits) women were under 60 years old and had a record of menses greater 
than 365 days from.  98 women (with 1437 visits) were over the age of 60 and of 
these women 133 women and 1924 visits for the postmenopausal analysis.   
99.5% of women over 60 years old were missing menstrual data, presumably 
because the clinician assumed they were past the final menstrual period. 
4.1.4 Transitioning Peri to Postmenopausal Women 
Within the perimenopausal women, thirteen met criteria to have transitioned from 
perimenopause into postmenopause by progressing to greater than 365 days 
since final menstrual period. 
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4.2 Sample Characteristics 
The majority (almost 90%) of the subjects were Caucasian and there was no 
significant difference between the three reproductive groups in bipolar subtype (I, 
II, or NOS) or rapid cycling status. Table 1. 
Age of first syndromal mood episode (for both mania and depression) was 
significantly different between the three reproductive groups with 
postmenopausal women having the oldest age of onset and reproductive age 
women the youngest.   Also, rates of comorbid anxiety disorders were 
significantly differed across reproductive groups (p=0.002) with the highest rates 
in reproductive age women (39%), the lowest in postmenopausal women (24%) 
and perimenopausal women (36%) in between. There were no significant 
differences across the three groups with respect to comorbid alcohol or 
substance use disorders. Table 1.  
Reproductive characteristics varied across the three reproductive cohorts (Table 
2). All three groups reported similar age of menarche and number of 
miscarriages, however postmenopausal women had more births and fewer 
abortions than the younger two groups. While there was no significant difference 
between the three groups in the percentage of women who reported postpartum 
mood exacerbation, significantly fewer postmenopausal women compared to the 
younger cohorts reported a history of perimenstrual mood exacerbation. 
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4.3 Overall Mood State Description by Reproductive Group 
There was a significant overall difference in number of visits in different mood 
states (recovered, symptomatic, depressed or elevated) at clinic visits between 
the reproductive age, perimenopausal and postmenopausal women with bipolar 
disorder, c2 (6, N = 9959) = 31.6, p <0.0001.  
An ordinal logistic regression model revealed a gradient of worsening mood state 
from reproductive age to perimenopausal (OR=1.08, 95% CI 0.906 – 1.289, 
p=0.4) and perimenopausal to postmenopausal women (OR=-0.07, 95% CI -0.32 
– 0.18, p=0.6). While there was no significant difference between the proportion 
of visits in a depressed, elevated or euthymic state between the three 
reproductive groups χ2 (2, N = 768) = 2.3, p=0.3 by generalized estimating 
equations, there was a significant increase in the proportion of visits in a 
symptomatic state from reproductive age (48±32%) to perimenopausal (51±28%) 
to postmenopausal (55±32%) women F(2, N=768) 3.0, p=0.05.Figure 2. 
4.4 Primary Hypothesis: Proportion of Visits with Syndromal Depression 
Across Reproductive Stages 
There was no significant difference in the proportion of visits with syndromal 
depression among reproductive age, perimenopausal and postmenopausal 
women when analyzed by clinic visit, χ2 (2, N = 9960) = 1.6, p=0.4. Nor were any 
of the reproductive group pair-wise comparisons significantly different in the 
proportion of clinic visits depressed. Table 3. 
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Similarly, when using a within woman analysis, there was no significant 
difference in the proportion of visits in a depressed state across reproductive age 
(17.8±2.5%) perimenopausal (18.2±2.3%) and postmenopausal (14.5±2.1%) 
women F(2, N=768) 1.09, p=0.3.  Figure 2. 
4.5 Secondary Hypotheses 
4.5.1 Proportion of Visits with Syndromal Mood Elevation across 
Reproductive Stages 
There was a significant overall difference in the proportion of visits with 
syndromal mood elevation (manic, hypomanic or mixed episodes) among 
reproductive age (5.3%), perimenopausal (4.1%) and postmenopausal (3.0%) 
women with bipolar disorder when analyzed by visit χ2 (2, N = 9960) = 19.5, p 
<0.0001. Figure 1.   
In a pair-wise comparison, reproductive age women had a significantly greater 
proportion of clinic visits in mood elevation than either postmenopausal (Z-
test=4.1, p<0.0001) or perimenopausal women (Z-test=2.1, p=0.03); while 
postmenopausal compared to perimenopausal women did not significantly differ 
in proportion of visits with syndromal mood elevation. Table 3. 
However, when analyzed by woman, there was no significant difference in the 
proportion of visits in a syndromal mood elevation between reproductive age 
(5.3±13%) perimenopausal (3.4±6%) and postmenopausal (3.2±8%) women F(2, 
N=765) 2.3 p=0.1. Figure 2. 
34 
 
 
 
4.5.2 Proportion of Visits in a Euthymic Mood across Reproductive Stages 
There was a significant overall difference in the proportion of visits in a euthymic 
healthy mood among the reproductive age (29.2%), perimenopausal  (28.0%) 
and postmenopausal  (26.0%) women with bipolar disorder when analyzed by 
visit χ2(2, N=9960)=7.7,p=0.02.  Figure 1. 
In a pair-wise comparison, postmenopausal women had a significantly smaller 
proportion of clinic visits in euthymic mood than reproductive age (Z-test=7.5, 
p<0.006) while there was no significant difference in the proportion of visits in a 
euthymic mood between reproductive age women and perimenopausal women 
(Z-test=1.2,p=0.3) or peri and postmenopausal women (Z-test=1.9,p=0.2). Table 
3. 
When analyzed by woman, there was no significant difference in the proportion 
of visits in a euthymic state between reproductive age (29±26%) perimenopausal 
(28±21%) and postmenopausal (27±23%) women F(2, N=768) 0.8,p=0.5. Figure 
2. 
4.5.3 History of Perimenstrual and or Postpartum Mood Exacerbation 
Of perimenopausal women with bipolar disorder, 46% gave a history of 
perimenstrual mood exacerbation, 42% gave a history of no perimenstrual mood 
exacerbation and 12% had missing data. Women with versus without a history of 
perimenstrual mood exacerbation did not significantly differ in proportion of visits 
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with syndromal depression (18% vs 19%) or with syndromal mood elevation (4% 
vs 4%) during the perimenopause.  
Of perimenopausal women with bipolar disorder, 30% gave a history of 
postpartum
Likewise, perimenopausal women with bipolar disorder who reported both 
 mood exacerbation, 40% gave a history of no postpartum mood 
exacerbation and 30% had missing postpartum mood data. Women with versus 
without a history of postpartum mood exacerbation did not significantly differ in 
proportion of visits with syndromal depression (18% vs 14%) or with syndromal 
mood elevation (3% vs 4%) during the perimenopause. 
perimenstrual and postpartum
4.5.4 Hormone Therapy Use 
 mood exacerbations (29%) did not significantly 
differ from those who reported no mood exacerbation at either time (24%) in the 
proportion of visits in a depression (18% vs 14%) or mood elevation (3% vs 3%) 
during the perimenopause.  Table 4. 
In the 28% of perimenopausal and postmenopausal women with bipolar disorder 
who used HT, 16% of their clinic visits were with syndromal depression and 2% 
were with syndromal mood elevation.  These ratios did not significantly differ 
from those of the 72% of women not using HT, in whom 16% of visits were with 
syndromal depression and 4% were with syndromal mood elevation.  Similarly, 
use of oral contraceptive pill by reproductive age women was not associated with 
a difference in proportion of visits elevated or depressed. Table 5. 
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Hormone Therapy use did not predict a greater proportion of visits in a 
depressed state by logistic regression χ2(2, N=768)=1.9,p=0.38.   
4.5.5 Women Transitioning from Perimenopause to Postmenopause 
Thirteen women had a recorded menstrual cycle transition from late 
menopausal transition to postmenopause.   These women experienced a 
significantly greater proportion of clinic visits in a syndromal depression women 
(24.4±18%) compared to reproductive age, non-transitioning perimenopausal or 
postmenopausal women χ2 (3, N = 9960) = 19.8, p <0.0002.  However, while a 
significant difference in proportion of visits in euthymia (29±14%) on comparison 
of the four reproductive groups was found χ2 (3, N = 9960) = 9, p =0.046, there 
was no notable difference of transition peri to postmenopausal women on a 
pairwise comparisons with reproductive age, non-transitioning perimenopausal 
and postmenopausal women.  Likewise, no significant difference in proportion of 
visits in a mood elevation (3.2±0.5%) was found in a pairwise comparison of the 
transitioning peri to post group compared to reproductive age, non-transitioning 
perimenopausal and postmenopausal women. 
These thirteen women did not have a significant within woman change in 
the proportion of clinic visits in a syndromal depression t (24)=0.8,p=0.4, 
syndromal elevation t (24)=-0.34,p=0.7 or euthymia t (24)=-0.7,p=0.5, from late 
transition to early postmenopause.   
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4.5.6 Mood state of included compared to excluded subjects 
There was an overall significant difference between included reproductive age, 
perimenopausal and postmenopausal women compared to excluded women of 
the corresponding age group in the proportion of clinic visits in euthymic, 
syndromal elevation, syndromal depression and symptomatic states χ2 (15, N = 
21989) = 138, p <0.0001.  
There was a significantly greater proportion of visits in a syndromal 
depression in excluded versus included premenopausal , χ2 (1, N = 8922) = 24, p 
<.0001, perimenopausal χ2 (1, N = 10990) = 12, p <.0005 and postmenopausal 
women χ2 (1, N = 2174) = 8.9 p <.003. However, there was no significant 
difference in the proportion of visits in a euthymic mood or syndromal elevation in 
included versus excluded women within the reproductive age, perimenopausal or 
postmenopausal age groups, χ2 (5, N = 22086) = 7.1, p=0.2).  Table 6. 
4.5.7 Mood State by Age 
For a visual comparison, the proportion of visits in the four mood states across 
five year age cohorts in women with bipolar disorder is presented in Figure 3.  
The proportion of visits in a syndromal mood elevation declines as age 
advances.  However, it is difficult to comment proportion of visits by age cohort in 
the other three mood groups as the sample size decreases significantly in the 
seventy years old and older groupings. 
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CHAPTER V 
5 CONCLUSIONS 
5.1 Summary of Findings 
5.1.1 Syndromal Bipolar Depression 
In contrast to our hypothesis, our findings did not show a significant difference in 
the proportion of clinic visits in a depressed state between reproductive age 
women, late transition perimenopausal women and postmenopausal women in 
either by visit or by woman analysis.   
5.1.2 Syndromal Mood Elevation  
The pervasiveness of syndromal mood elevations significantly decreased from 
reproductive age to perimenopausal to postmenopausal women with both 
perimenopausal and postmenopausal women experiencing significantly lower 
proportion of clinic visits in a mood elevated state than reproductive age women 
when analyzed by visit. While postmenopausal women had the numerically 
lowest proportion of visits in a syndromal mood elevation, the proportion did not 
differ significantly from perimenopausal women.  No significant difference in 
proportion of mood elevation visits by reproductive group was seen in a within 
woman analysis. In examining mood elevation by increasing five year age 
groups, a reduction of the proportion of visits in an elevated state by age was 
visually apparent. 
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5.1.3 Euthymic Mood  
The proportion of visits in a healthy euthymic mood significantly decline from 
reproductive age to perimenopausal to postmenopausal women giving a 
statistically lower proportion of euthymic clinic visits in postmenopausal 
compared to reproductive age women in the by visit analysis.  When analyzing 
within woman, no significant difference in visits in euthymic mood emerged. 
5.1.4 History of Mood Disruption Associated with Reproductive Events 
A reported history of mood exacerbation associated with the menstrual 
cycle and or postpartum was not associated with altered pervasiveness of 
syndromal depression or syndromal mood elevation during the perimenopause.  
5.1.5 Hormone Therapy 
Perimenopausal and postmenopausal women with bipolar disorder who 
used of hormone therapy compared to those who did not use HT, did not have a 
significantly different proportion of clinic visits with syndromal depression or 
mood elevation. 
5.1.6 Women Transitioning from Peri to Post Menopause 
The thirteen women who transitioned from perimenopause to 
postmenopause during study participation had a significantly greater proportion 
of clinic visits in a syndromal depression than the reproductive age, non-
transitioning perimenopausal and postmenopausal women.  Within these thirteen 
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transitioning women, the proportion of visits in a depressed state did not 
significantly differ during their perimenopausal time to their postmenopausal time. 
5.1.7 Mood State in Included compared to Excluded Women 
Excluded (primarily due to missing menstrual cycle data) reproductive age, 
perimenopausal age and postmenopausal age women had a significantly greater 
proportion of clinic visits in a syndromal depression than included like aged 
women; excluded women had no significant difference in the proportion of 
euthymic or syndromal elevation visits than included women. 
5.2  Discussion and Comparison to Published Data 
5.2.1 Bipolar Depression in Menopausal Transition 
 This study found no significant difference in the proportion of clinic visits in a 
syndromal depression experienced by reproductive age, late perimenopausal 
transition or postmenopausal women. This is in contrast to the few small studies 
in women with bipolar disorder that report significant or notable worsening of 
depression during the perimenopause compared to younger reproductive years 
either within woman by retrospective report (Freeman, Smith et al. 2002) or in 
contrast to a longitudinal report in concurrent cohort (Marsh, Templeton et al. 
2008; Marsh, Ketter et al. 2009).  This study’s results are in accordance with a 16 
year prospective study on clinical course of 95 patients with bipolar disorder 
finding ‘individual patients do not tend to go into depression with increasing age’ 
(Angst 1978). 
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 However, the thirteen women who transitioned from late perimenopause into 
postmenopause during study participation had a significantly greater proportion 
of visits in a syndromal depression than any of the original three reproductive 
groups.  Within the thirteen women who transitioned from late perimenopause to 
postmenopause there was no significant difference in rates of depression from 
the former to latter reproductive phase.  In the unipolar depression literature, both 
the menopausal transition and early postmenopause have been found to have an 
increased rate of depression (Bromberger, Schott et al. 2010; Freeman 2010). 
5.2.2 Mood Elevation in Menopausal Transition 
 Our findings of a decrease in syndromal mood elevations by aging reproductive 
group are consistent with a previous report of no increased risk of syndromal 
mood elevation during the perimenopause compared to the reproductive years 
(Marsh, Ketter et al. 2009).  Another study reported the perimenopause as a time 
of increased mood cycling in bipolar disorder (Kukopulos, Reginaldi et al. 1980).  
Our study may be the first to report a decreased
5.2.3 Euthymia and Menopausal Transition 
 rate of syndromal mood 
elevation in the perimenopause and postmenopause compared to reproductive 
years. 
   This study reports decreasing proportion of visits in a healthy euthymic state 
from the youngest reproductive age group to the oldest postmenopausal group; a 
result in accordance with the assertion that the natural course in bipolar disorder 
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is a worsening of symptoms over time, in this case apparent despite treatment. 
While a different design, in a recent 7yr prospective naturalistic follow up study 
individuals were found over time to have an increase in the number of euthymic 
visits (Altshuler, Kupka et al. 2010). 
5.2.4 Potential Confounders 
 Previous studies found substance use
 However, 
 associated with worse mood course in 
bipolar disorder. In our subjects, substance use between the three reproductive 
groups did not differ significantly, thus was unlikely to be a factor in mood 
episode differences.  
age of first mood episode
 
 (mania or depression) was significantly 
different between the three reproductive groups with onset being earliest in 
reproductive age group, intermediate in perimenopausal group, and latest in 
postmenopausal women.  This difference may be explained by a) earlier 
recognition of bipolar currently than in the past, b) postmenopausal women 
having a higher threshold until the disorder hit awareness, or c) a survivor effect 
in the women with later onset having less severe mood course and thus more 
often reaching the older postmenopausal age. Nevertheless, studies of pooled 
(male and female) adults with bipolar disorder have reported later onset in older 
than in younger subjects (Depp and Jeste 2004).  Earlier age of onset has been 
associated with worse mood course in STEP-BD (Perlis, Miyahara et al. 2004). 
Comorbid anxiety disorders have been associated with a worse mood course in 
bipolar disorder (Simon, Otto et al. 2004; Gaudiano and Miller 2005; Keller 2006; 
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Perlis, Ostacher et al. 2006; Altshuler, Kupka et al. 2010), and in the current 
study, were more prevalent in the reproductive age group, followed by the 
perimenopausal group, followed in turn by the postmenopausal group, a finding 
that has not been found previously reported. In a prior analysis of STEP-BD 
anxiety was associated with decreased time recovered (Simon, Otto et al. 2004) 
and yet in this study the reproductive age group had the greatest proportion of 
visits in a euthymic (recovering + recovered) state of the three groups. Comorbid 
anxiety disorders have also been associated with increased rates of depression 
in bipolar disorder (Gaudiano and Miller 2005; Altshuler, Kupka et al. 2010) and 
yet the reproductive group did not experience a greater rate of depression.  
Rather the reproductive age group experienced the greatest proportion of mood 
elevations which has not been reported associated with anxiety. 
5.2.5 History of Mood Exacerbation with Reproductive Events 
 Reporting a history of mood exacerbation in association with the postpartum 
period or menstrual cycle or both did not predict syndromal depression or 
syndromal mood elevation in the perimenopause in women with treated bipolar 
disorder. Thus, women with bipolar disorder in this study did not carry a lifelong 
vulnerability to mood episodes associated with reproductive events. This is in 
agreement with other retrospective studies (Payne, Roy et al. 2007; Marsh, 
Templeton et al. 2008).  However, our finding is in contrast to a case series of 
five women reporting increased risk of mood recurrence in the perimenopause in 
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women with a history of postpartum psychosis (Robertson Blackmore, Craddock 
et al. 2008).  
5.2.6 Bipolar Mood Episodes and Hormone Therapy 
Use of hormone therapy in perimenopausal and postmenopausal women with 
treated bipolar was not associated with lower proportion of visits with syndromal 
depression in this analysis.  While from this study it would appear that in women 
treated for bipolar disorder, HT did not confer antidepressant-like effects, HT may 
improve mood of users to that of non users. In a retrospective report of women 
with bipolar disorder, women who were not using hormone therapy were 
significantly more likely than those who were using HT to report worsening of 
symptoms during perimenopause (Freeman, Smith et al. 2002).  However, as 
previously reported by this author in a smaller study, women age 45-55 years 
who did and did not take HT had statistically similar proportions of clinic visits 
with syndromal depression (Marsh, Templeton et al. 2008).   
5.3  Strengths and Limitations 
5.3.1 Strengths 
 Strengths of this study include its large sample size compared to previous 
studies in the field. Longitudinal assessment averaged approximately a year and 
a half per patient. The non-randomized, open, naturalistic treatment subjects 
received generally reflects that seen in optimized evidence-based clinical 
practice. It is the first study to assess menstrual status in conjunction with mood 
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course in bipolar disorder. This study took a continuum approach to female 
reproductive life – from the reproductive years to perimenopause to 
postmenopause.  Mood at each clinic visit was classified by rigorous DSM-IV 
criteria, (although a less sensitive measure than other mood rating instruments).  
Analysis of mood state was performed both by clinic visit and by within woman 
comparison. Characteristics that may influence mood course for the worse in 
bipolar disorder were assessed.  Similarly a visual representation of the potential 
confounder of age compared to mood was included.   For thirteen women we 
were able to perform a within-individual comparison of mood state from 
perimenopause to postmenopause.  
5.3.2 Limitations 
 Limitations include a significant amount of missing data from the database, 
particularly menstrual cycle reporting.  Thus, perimenopausal women may have 
been mistakenly classified as postmenopausal if a menstrual cycle occurred but 
was not reported.  Proportion of clinic visits in a mood state does not necessarily 
translate into duration of a mood episode, as patients likely attend doctor visits 
more often during syndromal mood episode than when euthymic. Thus, while 
presence of mood episode was defined, the duration and severity of mood 
episodes were not accounted for in the analysis of the impact of reproductive 
phase upon mood.  
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 The absence of baseline and longitudinal endocrinological assessment, as well 
as systematic assessments of medical and psychosocial stressors represent 
additional limitations.  
   The relatively brief duration of the current study did not permit more than 
thirteen transitioning perimenopausal to postmenopause within-individual 
comparisons of mood across reproductive phases.  
 It could be that smaller sample size and hence more limited statistical power 
could have attenuated ability to demonstrate differences between the 
reproductive groups.  
Exclusion of women in the correct reproductive group age ranges was 
primarily due to missing menstrual cycle data.  While these excluded women did 
not differ from included women in proportion of visits in a syndromal mood 
elevation or euthymic state, they were significantly more likely to be in a 
syndromal depressed than included women in all three reproductive age groups.  
This brings to question whether there may have been a nonrandom reason for 
the missing data.  For example, in excluded women clinic time was prioritized for 
discussing options for difficult to treat bipolar depression and not on obtaining 
menstrual cycle data.  This missing data might have modified findings of this 
study.  
Limitations: Included vs Excluded Women 
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5.4  Future Work  
 Future studies are warranted, including research prospectively tracking 
menstrual cycle and mood course in women with bipolar disorder through the 
early and late perimenopause and early postmenopause.  In such research, at 
entry women ought to undergo a diagnostic interview based on DSM-IV 
diagnostic criteria and provide detailed histories of menstrual status. Via a staged 
study design, women in each reproductive category need to be followed for 
several (at least four) months with daily mood, medication, life events, and 
menstrual cycle assessments using mood tracking software (such as 
ChronoRecord) and monthly with standardized mood ratings and reproductive 
endocrinological assessment of estradiol and follicle stimulating hormone (FSH). 
Clinical Global Impression scale should also be performed monthly as a sensitive 
measure to change in mood severity. Such a design would address several 
important limitations (missing menstrual cycle reporting, unclear duration and 
severity of mood episodes, lack of endocrinological assessments, lack of 
structured assessments of social stressors) of the current study. 
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TABLES and FIGURES 
 
 
Table 1. Subject Characteristics 
 
 
Premenopausal1  
(n=519) 
Perimenopausal2  
(n=116) 
Postmenopausal3  
(n=133) 
Premenopausal, 
Perimenopausal, 
and 
Postmenopausal 
Groups Combined 
(n=768) 
P-value N (%) N (%) N (%) N (%) 
Number of clinical observations 5989 2046 1925 9960  
Race 
White or Caucasian                        
      Black or African American                  
Other       
 
460 (89) 
30 (6) 
29 (5) 
 
102 (88) 
13 (11) 
1 (1) 
 
119 (89) 
10 (8) 
4 (3) 
 
681 (89) 
53 (7) 
34 (4) 
 
0.0464 
 
Bipolar Diagnosis 
Bipolar I 
Bipolar II 
Bipolar NOS 
Schizoaffective Disorder 
 
317 (61) 
166 (32) 
31 (6) 
5 (1) 
 
67 (58) 
42 (36) 
5 (4) 
2 (2) 
 
87 (65) 
37 (28) 
8 (6) 
1 (1) 
 
471 (61) 
245 (32) 
44 (6) 
8 (1) 
 
0.7943 
Rapid cycling 
Yes 
No 
 
160 (31) 
152 (29) 
 
39 (34) 
34 (29) 
 
35 (26) 
57 (43) 
 
234 (30) 
243 (32) 
 
0.0596 
Current Substance Abuse or 
Dependency 
Yes 
No 
 
14 (3) 
505 (97) 
  
3 (3) 
112 (97) 
 
1 (1) 
131 (99) 
 
18 (2) 
748 (98) 
 
0.3219* 
Current Alcohol Abuse or Dependency 
Yes 
No 
 
31 (6) 
486 (94) 
 
7 (6) 
106 (91) 
 
5 (4) 
126 (95) 
 
43 (6) 
718 (93) 
 
0.6051 
Number of Previous Episodes 
0 
1-2 
3-4 
5-6 
7 
 
3 (0.6) 
20 (4) 
34 (7) 
160 (31) 
109 (21) 
 
2 (2) 
0 (0) 
5 (4) 
46 (39) 
21 (18) 
 
5 (4) 
5 (4) 
2 (2) 
61 (46) 
17 (13) 
 
10 (1) 
25 (3) 
41 (5) 
267 (35) 
147 (19) 
 
0.0002* 
Anxiety Diagnosis 
Yes  
No 
 
201 (39) 
318 (61) 
 
44 (38) 
72 (62) 
 
30 (23) 
103 (77) 
 
275 (36) 
493 (64) 
 
0.0021 
HRT Use 
Yes 
No 
 
65 (13) 
454 (87) 
 
20 (17) 
96 (83) 
 
49 (37) 
84 (63) 
 
134 (17) 
634 (83) 
 
<.0001 
  Mean (SD) 
Range 
Mean (SD) 
Range 
Mean (SD) 
Range 
Mean (SD) 
Range 
P-value 
(ANOVA) 
Age at entry 33.09 (3.21) 28-38 
47.96 (3.80) 
42-59 
60.95 (8.68) 
42-83 
 <.0001 
Height (inches) 65.05 (3.05) 53-74 
64.68 (2.97) 
59-77.50 
64.69 (3.27) 
56.50-78 
64.93 (3.08) 
53-78 
0.4021 
Weight (pounds) 164.71 (44.69) 95-379 
179.36 (42.15) 
105-288 
173.55 (42.68) 
102-376 
168.21 (44.29) 
95-379 
0 0076 
Total Bipolar Index  72.13 (16.07) 25-100 
71.51 (14.79) 
30-100 
72.37 (15.79) 
25-100 
72.08 (15.82) 
25-100 
0 9075 
Age at Onset of Depression  16.40 (6.59) 3-37 
19.32 (9.94) 
5-46 
25.88 (13.41) 
4-61 
18.45 (9.32) 
3-61 
<.0001 
Age at Onset of Mania 20.32 (6.90) 2-36 
24.98 (10.76) 
5-45 
30.08 (13.58) 
6-67 
22.72 (9.76) 
2-67 
<.0001 
Months in Clinic 17.29 (14.23) 0-57.50 
28.65 (17.02) 
0-60.88 
22.15 (15.73) 
0-59.30 
19.84 (15.49)               
0-60.88 
<.0001 
Average Number of Visits 11.54 (11.78) 1-86 
17.64 (13.39) 
1-72 
14.47 (12.74) 
1-63 
12.97 (12.39) 
1-86 
<.0001 
Average Number of Visits a  Month 0.86 (0.67) 0.04-4.35 
0.72 (0.44) 
0.11-2.61 
0.78 (0.55) 
0.12-4.68 
0.82 (0.62)        
0.04-4.68 
0 0562 
*P-values for categorical variables from chi-square test unless asterisk is present.  Asterisk designates p-value from likelihood ratio chi-
square.  
1 Premenopausal: 28-38 years old, 0-60 days since last menstrual cycle 
2Perimenopausal: 42-60 years old with history of a menstrual cycle in last 2-12 months 
3Postmenopausal: over 42 years old with no menstruation for at least 12 months 
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Table 2. Reproductive History of Subjects 
 
 
Premenopausal1  
(n=519) 
Perimenopausal2  
(n=116) 
Postmenopausal3  
(n=133) 
Premenopausal, 
Perimenopausal, 
and 
Postmenopausal 
Groups Combined 
(n=768) 
P-value N (%) N (%) N (%) N (%) 
History of Postpartum Exacerbation of 
Depression 
Yes 
No 
 
 
116 (22) 
151 (29) 
 
 
35 (30) 
47 (41) 
 
 
42 (32) 
69 (52) 
 
 
193 (25) 
267 (35) 
 
 
0.5963 
History of Perimenstrual Exacerbation of 
Depression 
Yes 
No 
 
 
258 (50) 
214 (41) 
 
 
53 (46) 
49 (42) 
 
 
33 (25) 
87 (65) 
 
 
344 (45) 
350 (46) 
 
 
<.0001 
Number of Miscarriages 
0 
1 
2 
3+ 
 
172 (33) 
42 (8) 
14 (3) 
10 (2) 
 
45 (39) 
15 (13) 
5 (4) 
3 (3) 
 
68 (51) 
12 (9) 
5 (4) 
4 (3) 
 
285 (37) 
69 (9) 
24 (3) 
17 (2) 
 
0.8754* 
Number of Abortions 
0 
1 
2 
3+ 
 
141 (27) 
62 (12) 
28 (5) 
10 (2) 
 
41 (35) 
16 (14) 
5 (4) 
5 (4) 
 
77 (58) 
8 (6) 
1 (0.8) 
2 (2) 
 
259 (34) 
86 (11) 
34 (4) 
17 (2) 
 
0.0001 
Number of Live Births 
0 
1 
2 
3+ 
 
63 (12) 
76 (15) 
72 (14) 
38 (7) 
 
12 (10) 
17 (15) 
24 (21) 
19 (16) 
 
5 (4) 
12 (9) 
40 (30) 
37 (28) 
 
80 (10) 
105 (14) 
136 (18) 
94 (12) 
 
<.0001 
Current Contraceptive Method 
None 
Oral birth control 
Barrier 
Abstinence 
Other 
 
158 (30) 
80 (15) 
92 (18) 
54 (10) 
83 (16) 
 
53 (46) 
5 (4) 
6 (5) 
8 (7) 
30 (26) 
 
74 (56) 
4 (3) 
2 (2) 
5 (4) 
29 (22) 
 
285 (37) 
89 (12) 
100 (13) 
67 (9) 
142 (18) 
 
<.0001 
 Mean (SD) 
Range 
Mean (SD) 
Range 
Mean (SD) 
Range 
Mean (SD) 
Range 
P-value 
(ANOVA) 
Age at First Menarche 12.61 (1.68) 
8-18 
12.57 (1.71) 
9-18 
12.69 (1.75) 
8-19 
12.62 (1.70) 
8-19 
0.8771 
Number of Live Births 1.42 (1.20) 
0-7 
1.83 (1.29) 
0-6 
2.41 (1.26) 
0-6 
1.72 (1.29) 
0-7 
<.0001 
*P-values for categorical variables from chi-square test unless asterisk is present.  Asterisk designates p-value from likelihood ratio chi-
square.  
1 Premenopausal: 28-38 years old, 0-60 days since last menstrual cycle 
2Perimenopausal: 42-60 years old with history of a menstrual cycle in last 2-12 months 
3Postmenopausal: over 42 years old with no menstruation for at least 12 months 
 
 
 
50 
 
 
 
 
Table 3. Pair-wise Comparisons of Proportion of Clinic Visits in 
Depression, Mood Elevation or Euthymia by Reproductive Cohort 
 
P-values are from a z-test of two proportions (a test used to compare the proportions from two independent groups to 
determine if they are significantly different from one another) 
*P-values significant at 0 05 level. 
 
     
Pair-wise Comparison Mood State Proportion of Visits in Mood State 
(%) 
Z-test for 
Proportion 
Value; P value 
 Syndromal Depression   
Reproductive age vs 
Perimenopause 
 18.1 vs 18.1 Z=-0.01. p=0.9 
Reproductive age vs 
Postmenopause 
 18.1 vs 19.3 Z=1.1; p=0.2 
Peri- vs Post-Menopause  18.1 vs 19.3 Z=0.9; p=0.3 
 Syndromal Elevation   
Reproductive age vs 
Perimenopause 
 5.3 vs 4.1 Z=2.1; p=0.03* 
Reproductive age vs 
Postmenopause 
  5.3 vs 3.0 Z=4.1, p<0.001*    
Peri- vs Post-Menopause  4.1 vs 3.0 Z=1.8. p=0.06 
 Euthymia   
Reproductive age vs 
Perimenopause 
 29.2 vs 28.0 Z=1.0, p=0.3 
Reproductive age vs 
Postmenopause 
 29.2 vs 26.0 Z=2.7, p=0.007* 
Peri- vs Post-Menopause  28.0 vs 26.0 Z=1.4;p=0.2 
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Table 4. Proportion of Visits in a Depression or Mood Elevation by 
Reproductive Group Reporting a Positive or Negative History of 
Perimenstrual and or Postpartum  Mood Exacerbation. 
Reproductive Group 
Perimenstrual 
Exacerbation 
(by woman) 
N (%) 
Average Proportion 
(%) of visits in a 
Syndromal 
Depression 
 
P-
Value* 
Average Proportion 
(%) of visits in 
Syndromal Mood 
Elevation 
 
P-
Value* 
Premenopausal 
(Nwomen=519) 
PM + 
PM -  
 
 
258 (50) 
214 (41) 
 
 
18 
18 
Z=-0.12 
P=0.90 
 
 
5 
5 
Z=-0.21 
P=0.83 
Perimenopausal 
(Nwomen=116) 
PM + 
PM -  
 
 
53 (46) 
49 (42) 
 
 
18 
19 
Z=-0.13 
P=0.90 
 
 
4 
4 
Z=-0.51 
P=0.61 
Postmenopausal 
(Nwomen=133) 
PM + 
PM - 
 
 
33 (25) 
87 (65) 
 
 
18 
10 
Z=0.87 
P=0.38 
 
 
2 
4 
Z=-
0.024 
P=0. 98 
Reproductive Group 
Postpartum Mood 
Exacerbation (by 
woman) 
N (%)   
 
 
Premenopausal 
(Nwomen=519) 
PP + 
PP -  
 
 
116 (22) 
151 (29) 
 
 
21 
17 
Z=0.67 
P=0.50 
 
 
6 
4 
Z=0.46 
P=0.64 
Perimenopausal 
(Nwomen=116) 
PP + 
PP -  
 
 
35 (30) 
47 (40) 
 
 
18 
14 
Z=0.19 
P=0.85 
 
 
3 
4 
Z=-0.35 
P=0.72 
Postmenopausal 
(Nwomen=133) 
PP + 
PP - 
 
 
42 (32) 
69 (52) 
 
 
14 
15 
Z=-
0.013 
P=.089 
 
 
2 
3 
Z=-0.29 
P=0.77 
 
Reproductive Group 
Perimenstrual and 
Postpartum (by 
woman) 
N (%)     
Premenopausal 
(Nwomen=519) 
Both  
Neither  
 
 
74 (14) 
89 (17) 
 
 
20 
14 
Z=0.81 
P=0.41 
 
 
6 
4 
Z=0.22 
P=0.82 
Perimenopausal 
(Nwomen=116) 
Both  
Neither  
 
 
23 (29) 
28 (24) 
 
 
18 
14 
Z=0.004 
P=0.99 
 
 
3 
3 
Z=-0.72 
P=0.46 
Postmenopausal 
(Nwomen=133) 
Both  
Neither  
 
 
15 (11) 
54 (41) 
 
 
14 
10 
Z=0.-
029 
P=0.97 
 
 
0.4 
4 
Z=0.053 
P=0.95 
PM = history of perimenstrual  exacerbation  (+ = yes;  - = no)  
PP = history of poatpartum  exacerbation  (+ = yes;  - = no) 
Both = history of PM and PP 
Neither = No history of PM nor PP 
*P-values are from a z-test of two proportions (a test used to compare the proportions from two independent groups to 
determine if they are significantly different from one another) 
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Table 5. Proportion of Visits in a Depression or Mood Elevation by 
Exogenous Hormone Use 
Reproductive Group 
Exogenous 
Hormone Use 
(by woman) 
 
N (%) 
Average Proportion (%) 
of visits in a Syndromal 
Depression 
P-
Value* 
Average Proportion (%) 
of visits in Syndromal  
Mood Elevation 
P-
Value* 
Premenopausal 
(Nwomen=519) 
OCP + 
OCP -  
 
 
65 (13) 
454 (87) 
 
 
14 
18 
 
Z=0.62 
P=0.54 
 
 
6 
5 
Z=0.041 
P=0.97 
Peri  & 
Postmenopausal 
(Nwomen=249) 
HT + 
HT  - 
 
 
 
69 (28) 
180 (72) 
 
 
 
16 
16 
 
 
Z=-0.19 
P=0.85 
 
 
 
2 
4 
 
 
Z=-0.40 
P=0.69 
HT = Hormone Therapy 
OCP = Oral Contraceptive Pill 
*P-values are from a z-test of two proportions (a test used to compare the proportions from two independent groups to 
determine if they are significantly different from one another) 
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Table 6.  Proportion of Visits in Mood State by Reproductive Age Group: 
Included vs Excluded Women 
 
Mood State Reproductive Age Group 
 Pre 
Include
d 
n=519 
Pre 
Exclude
d 
n=118 
Peri 
Include
d 
n=116 
Peri 
Exclude
d n=654 
Post 
Include
d 
N=133 
Post 
Exclude
d n=5 
Total 
visits 
Syndromal 
Depression 
 
18.66% 
 
29.10%
* 
 
18.61% 
 
21.96%
* 
 
19.73% 
 
32.00%
* 
 
4475 
Syndromal 
Mood 
Elevation 
 
5.71% 
 
6.35% 
 
4.18% 
 
4.12% 
 
2.99% 
 
2.00% 
 
1027 
Euthymic  28.30% 30.16% 27.30% 27.14% 26.00% 32.00% 6067 
 
Symptomati
c 
47.33% 34.39% 49.90% 46.77% 51.28% 34.00% 1042
0 
 
Total 
Number of 
Visits 
8303 567 2509 8437 2073 100 2198
9 
*p<0.05 
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Figure 1. Proportion of Clinic Visits in Mood State by Reproductive Cohort 
of Women with Bipolar Disorder, by Visit
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Figure 2. Proportion of Clinic Visits in Mood State by Reproductive Phase in Women with 
Bipolar Disorder, by Woman
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